In vitro effects of brominated flame retardants and metabolites on CYP17 catalytic activity: A novel mechanism of action?

Alaee, 2003, An overview of commercially used brominated flame retardants, their applications, their use patterns in different countries/regions and possible modes of release, Environ. Int., 29, 683, 10.1016/S0160-4120(03)00121-1 Asplund, 1999, Organohalogen substances in muscle, egg and blood from healthy Baltic salmon (Salmo salar) and Baltic salmon that produced offspring with the M74 syndrome, Ambio, 28, 67 Canton, 2005, Inhibition and induction of aromatase (CYP19) activity by brominated flame retardants in H295R human adrenocortical carcinoma cells, Toxicol. Sci., 88, 447, 10.1093/toxsci/kfi325 Chen, 2004, Adrenal androgens and the immune system, Semin. Reprod. Med., 22, 369, 10.1055/s-2004-861553 Ciolino, 2003, Dehydroepiandrosterone inhibits the expression of carcinogen-activating enzymes in vivo, Int. J. Cancer, 105, 321, 10.1002/ijc.11075 Cleary, 1984, Metabolic consequences of dehydroepiandrosterone in lean and obese adult Zucker rats, Horm. Metab. Res., 16, 43 Darnerud, 2003, Toxic effects of brominated flame retardants in man and in wildlife, Environ. Int., 29, 841, 10.1016/S0160-4120(03)00107-7 Darnerud, 2001, Polybrominated diphenyl ethers: occurrence, dietary exposure, and toxicology, Environ. Health Perspect., 109, 49, 10.2307/3434846 de Wit, 2002, An overview of brominated flame retardants in the environment, Chemosphere, 46, 583, 10.1016/S0045-6535(01)00225-9 Denizot, 1986, Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability, J. Immunol. Methods, 89, 271, 10.1016/0022-1759(86)90368-6 Gazdar, 1990, Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis, Cancer Res., 50, 5488 Gribble, 1996, Naturally occurring organohalogen compounds—a comprehensive survey, Fortschr. Chem. Org. Naturst., 68, 1 Haglund, 1997, Identification and quantification of polybrominated diphenyl ethers and methoxy-polybrominated diphenyl ethers in Baltic biota, Environ. Sci. Technol., 31, 3281, 10.1021/es9702834 Hakk, 2003, Metabolism in the toxicokinetics and fate of brominated flame retardants—a review, Environ. Int., 29, 801, 10.1016/S0160-4120(03)00109-0 Hakk, 2002, Tissue disposition, excretion and metabolism of 2,2′,4,4′,5-pentabromodiphenyl ether (BDE-99) in the male Sprague–Dawley rat, Xenobiotica, 32, 369, 10.1080/00498250110119117 Heneweer, 2004, A comparison of human H295R and rat R2C cell lines as in vitro screening tools for effects on aromatase, Toxicol. Lett., 146, 183, 10.1016/j.toxlet.2003.10.002 Hites, 2004, Polybrominated diphenyl ethers in the environment and in people: a meta-analysis of concentrations, Environ. Sci. Technol., 38, 945, 10.1021/es035082g Hovander, 2002, Identification of hydroxylated PCB metabolites and other phenolic halogenated pollutants in human blood plasma, Arch. Environ. Contam. Toxicol., 42, 105, 10.1007/s002440010298 Kierkegaard, 2004, Polybrominated diphenyl ethers (PBDEs) and their methoxylated derivatives in pike from Swedish waters with emphasis on temporal trends, 1967–2000, Environ. Pollut., 130, 187, 10.1016/j.envpol.2003.12.011 Labrie, 2003, Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone, Endocr. Rev., 24, 152, 10.1210/er.2001-0031 LaCagnin, 1989, Inhibition of adrenocortical, mitochondrial and microsomal monooxygenases by SU-10′603, a steroid 17 alpha-hydroxylase inhibitor, J. Steroid Biochem., 33, 599, 10.1016/0022-4731(89)90047-2 Law, 2003, Levels and trends of polybrominated diphenylethers and other brominated flame retardants in wildlife, Environ. Int., 29, 757, 10.1016/S0160-4120(03)00110-7 Legler, 2003, Are brominated flame retardants endocrine disruptors?, Environ. Int., 29, 879, 10.1016/S0160-4120(03)00104-1 Lilienthal, 2006, Effects of developmental exposure to 2,2,4,4,5-pentabromodiphenyl ether (PBDE-99) on sex steroids, sexual development, and sexually dimorphic behavior in rats, Environ. Health Perspect., 114, 194, 10.1289/ehp.8391 Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Marsh, 1999, Synthesis and characterisation of 32 polybrominated diphenyl ethers, Environ. Sci. Technol, 33, 3033, 10.1021/es9902266 Marsh, 2004, Identification of hydroxylated and methoxylated polybrominated diphenyl ethers in Baltic Sea salmon (Salmo salar) blood, Environ. Sci. Technol., 38, 10, 10.1021/es034671j Meerts, 2000, Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro, Toxicol. Sci., 56, 95, 10.1093/toxsci/56.1.95 Meerts, 2001, In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PDBEs, and polybrominated bisphenol A compounds, Environ. Health Perspect., 109, 399, 10.1289/ehp.01109399 Moran, 2003, Molecular target of endocrine disruption in human luteinizing granulosa cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin: inhibition of estradiol secretion due to decreased 17alpha-hydroxylase/17,20-lyase cytochrome P450 expression, Endocrinology, 144, 467, 10.1210/en.2002-220813 Morck, 2003, Decabromodiphenyl ether in the rat: absorption, distribution, metabolism, and excretion, Drug Metab. Dispos., 31, 900, 10.1124/dmd.31.7.900 Noren, 2000, Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20–30 years, Chemosphere, 40, 1111, 10.1016/S0045-6535(99)00360-4 Olsen, 2002, Brominated phenols: characterization of estrogen-like activity in the human breast cancer cell-line MCF-7, Toxicol. Lett., 129, 55, 10.1016/S0378-4274(01)00469-6 Orn, 1998, Metabolism of 2,2′,4,4′-tetrabromodiphenyl ether in rat and mouse, Xenobiotica, 28, 199 Örn, 1996, Synthesis and characterisation of polybrominated diphenyl ethers-unlabeled and radiolabelled tetra-, penta- and hexabrominated diphenyl ethers, Acta Chem. Scand., 50, 802, 10.3891/acta.chem.scand.50-0802 Ronisz, 2004, Effects of the brominated flame retardants hexabromocyclododecane (HBCDD), and tetrabromobisphenol A (TBBPA), on hepatic enzymes and other biomarkers in juvenile rainbow trout and feral eelpout, Aquat. Toxicol., 69, 229, 10.1016/j.aquatox.2004.05.007 Rutten, 1987, Interlaboratory comparison of total cytochrome P-450 and protein determinations in rat liver microsomes. Reinvestigation of assay conditions, Arch. Toxicol., 61, 27, 10.1007/BF00324544 Sanders, 2006, Metabolism and disposition of 2,2′,4,4′-tetrabromodiphenyl ether following administration of single or multiple doses to rats and mice, Xenobiotica, 36, 103, 10.1080/00498250500485107 Sanderson, 2000, 2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: a novel mechanism for estrogenicity?, Toxicol. Sci., 54, 121, 10.1093/toxsci/54.1.121 Sanderson, 2002, Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells, Toxicol. Appl .Pharmacol., 182, 44, 10.1006/taap.2002.9420 Sandholm, 2003, Bioavailability and half-life of decabromodiphenyl ether (BDE-209) in rat, Xenobiotica, 33, 1149, 10.1080/00498250310001609156 Sanderson, 2004, Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells, Toxicol. Sci., 82, 70, 10.1093/toxsci/kfh257 Schwartz, 1979, Inhibition of spontaneous breast cancer formation in female C3H(Avy/a) mice by long-term treatment with dehydroepiandrosterone, Cancer Res., 39, 1129 Schwartz, 2004, Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity, Ageing Res. Rev., 3, 171, 10.1016/j.arr.2003.05.001 Sellstrom, 2003, Temporal trend studies on tetra- and pentabrominated diphenyl ethers and hexabromocyclododecane in guillemot egg from the Baltic Sea, Environ. Sci. Technol., 37, 5496, 10.1021/es0300766 Stapleton, 2004, Debromination of the flame retardant decabromodiphenyl ether by juvenile carp (Cyprinus carpio) following dietary exposure, Environ. Sci. Technol., 38, 112, 10.1021/es034746j Staskal, 2005, Toxicokinetics of BDE 47 in female mice: effect of dose, route of exposure, and time, Toxicol. Sci., 83, 215, 10.1093/toxsci/kfi018 Stoker, 2004, Assessment of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture, in the EDSP male and female pubertal protocols, Toxicol. Sci., 78, 144, 10.1093/toxsci/kfh029 Stoker, 2005, In vivo and in vitro anti-androgenic effects of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture, Toxicol. Appl. Pharmacol., 207, 78, 10.1016/j.taap.2005.05.010 Thomas, 2005, Absorption of decabromodiphenyl ether and other organohalogen chemicals by grey seals (Halichoerus grypus), Environ. Pollut., 133, 581, 10.1016/j.envpol.2004.06.011 Thuresson, 2005, Occupational exposure to commercial decabromodiphenyl ether in workers manufacturing or handling flame-retarded rubber, Environ. Sci. Technol., 39, 1980, 10.1021/es048511z Valters, 2005, Polybrominated diphenyl ethers and hydroxylated and methoxylated brominated and chlorinated analogues in the plasma of fish from the Detroit River, Environ. Sci. Technol., 39, 5612, 10.1021/es0506410 Viberg, 2003, Neonatal exposure to polybrominated diphenyl ether (PBDE 153) disrupts spontaneous behaviour, impairs learning and memory, and decreases hippocampal cholinergic receptors in adult mice, Toxicol. Appl. Pharmacol., 192, 95, 10.1016/S0041-008X(03)00217-5 Viberg, 2003, Neurobehavioral derangements in adult mice receiving decabrominated diphenyl ether (PBDE 209) during a defined period of neonatal brain development, Toxicol. Sci., 76, 112, 10.1093/toxsci/kfg210 Zhou, 2002, Developmental exposure to brominated diphenyl ethers results in thyroid hormone disruption, Toxicol. Sci., 66, 105, 10.1093/toxsci/66.1.105